Finding accredited CPD
This review summarises the essential features of the Easyhaler, a carbon neutral, dry powder inhaler that offers an effective, sustainable and easy-to-use alternative to pressurised metereddose inhalers. The Easyhaler device was registered in Australia in 2022 and is indicated for certain patients with asthma or chronic obstructive pulmonary disease. This review will focus on its role in asthma management as an environmentally conscious treatment option.
Independent expert commentary provided by Clinical Professor John Blakey.
This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
